Expired
Lead Plaintiff Deadline
Dec 8, 2023
Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that Kenvue Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Kenvue faces potential headwinds as a result of confirmed concerns about the efficacy of phenylephrine, which it knew or should have known; (2) Kenvue did not discuss risks relating to the efficacy of phenylephrine (or “PE”) in its IPO, the utility of which had been questioned since at least 2007; (3) while the Company disclosed risks relating to litigation, it did not disclose specific risk relating to potential litigation arising from adverse findings on the efficacy of phenylephrine; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times and negligently prepared.
In order to be eligible to join the KVUE class action lawsuit, you must have incurred a loss on shares of Kenvue purchased during the class period listed above.
If you suffered a loss in Kenvue during the relevant time frame, you have until December 8, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP
